154 related articles for article (PubMed ID: 32946960)
21. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
Olateju SO; Ajayi AA
Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
[TBL] [Abstract][Full Text] [Related]
22. How can the bioavailability of timolol be enhanced? A pharmacokinetic pilot study of novel hydrogels.
von der Ohe N; Stark M; Mayer H; Brewitt H
Graefes Arch Clin Exp Ophthalmol; 1996 Jul; 234(7):452-6. PubMed ID: 8817289
[TBL] [Abstract][Full Text] [Related]
23. Improvement of the ocular bioavailability of timolol by sorbic acid.
Higashiyama M; Inada K; Ohtori A; Tojo K
Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
[TBL] [Abstract][Full Text] [Related]
24. Influence of betaxolol and timolol on the venous tone in glaucoma patients.
Bojic L; Bagatin J; Ivanisevic M; Hozo I; Racic G; Karelovic D
Int Ophthalmol; 1999; 23(3):149-53. PubMed ID: 11456252
[TBL] [Abstract][Full Text] [Related]
25. Effects of beta antagonists on mechanical properties in rabbit ciliary artery.
Hayashi-Morimoto R; Yoshitomi T; Ishikawa H; Hayashi E; Sato Y
Graefes Arch Clin Exp Ophthalmol; 1999 Aug; 237(8):661-7. PubMed ID: 10459616
[TBL] [Abstract][Full Text] [Related]
26. Ocular and retrobulbar blood flow in ocular hypertensives treated with topical timolol, betaxolol and carteolol.
Steigerwalt RD; Laurora G; Belcaro GV; Cesarone MR; De Sanctis MT; Incandela L; Minicucci R
J Ocul Pharmacol Ther; 2001 Dec; 17(6):537-44. PubMed ID: 11777177
[TBL] [Abstract][Full Text] [Related]
27. Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy.
Sponsel WE; Terry S; Khuu HD; Lam KW; Frenzel H
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S210-3. PubMed ID: 10416765
[TBL] [Abstract][Full Text] [Related]
28. Absorption of ocular timolol: drug concentrations and beta-receptor binding activity in the aqueous humour of the treated and contralateral eye.
Saari KM; Ali-Melkkilä T; Vuori ML; Kaila T; Iisalo E
Acta Ophthalmol (Copenh); 1993 Oct; 71(5):671-6. PubMed ID: 7906472
[TBL] [Abstract][Full Text] [Related]
29. Effect of topical betablockers on human retinal vessels diameters.
Collignon NJ; Collignon-Brach JD
Int Ophthalmol; 1997-1998; 21(4):199-203. PubMed ID: 9700006
[TBL] [Abstract][Full Text] [Related]
30. Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.
Ros FE; Innemee HC; van Zwieten PA
Doc Ophthalmol; 1980 Apr; 48(2):291-301. PubMed ID: 6105048
[TBL] [Abstract][Full Text] [Related]
31. Comparison of ophthalmic beta-blocking agents.
Lesar TS
Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
[TBL] [Abstract][Full Text] [Related]
32. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
Strahlman E; Tipping R; Vogel R
Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
[TBL] [Abstract][Full Text] [Related]
33. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Frishman WH; Fuksbrumer MS; Tannenbaum M
J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
[TBL] [Abstract][Full Text] [Related]
34. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol.
Evans DW; Harris A; Cantor LB
J Ocul Pharmacol Ther; 1999 Dec; 15(6):479-87. PubMed ID: 10609770
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method.
Ohtori R; Sato H; Fukuda S; Ueda T; Koide R; Kanda Y; Kiuchi Y; Oguchi K
Exp Eye Res; 1998 Apr; 66(4):487-94. PubMed ID: 9593641
[TBL] [Abstract][Full Text] [Related]
36. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
[TBL] [Abstract][Full Text] [Related]
37. Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation.
Vuori ML; Ali-Melkkilä T; Kaila T; Iisalo E; Saari KM
Acta Ophthalmol (Copenh); 1993 Oct; 71(5):682-5. PubMed ID: 7906474
[TBL] [Abstract][Full Text] [Related]
38. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
[TBL] [Abstract][Full Text] [Related]
39. The effect of timolol, betaxolol and levobunolol on the surface of rabbit cornea.
Follmann P; Varga M; Daróczy J
Int Ophthalmol; 1989 Jan; 13(1-2):81-4. PubMed ID: 2663750
[TBL] [Abstract][Full Text] [Related]
40. Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation.
Yamamura K; Sasaki H; Nakashima M; Ichikawa M; Mukai T; Nishida K; Nakamura J
Pharm Res; 1999 Oct; 16(10):1596-601. PubMed ID: 10554103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
